Robben JH - Search Results

1

Relief of nocturnal enuresis by desmopressin is kidney and vasopressin type 2 receptor independent.

Robben JH, Sze M, Knoers NV, Eggert P, Deen P, Müller D. Robben JH, et al. J Am Soc Nephrol. 2007 May;18(5):1534-9. doi: 10.1681/ASN.2006080907. Epub 2007 Mar 27. J Am Soc Nephrol. 2007. PMID: 17389737 Free article.

2

Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus.

Robben JH, Knoers NV, Deen PM. Robben JH, et al. Am J Physiol Renal Physiol. 2006 Aug;291(2):F257-70. doi: 10.1152/ajprenal.00491.2005. Am J Physiol Renal Physiol. 2006. PMID: 16825342 Free article. Review.

3

Pharmacological chaperones in nephrogenic diabetes insipidus: possibilities for clinical application.

Robben JH, Deen PM. Robben JH, et al. BioDrugs. 2007;21(3):157-66. doi: 10.2165/00063030-200721030-00003. BioDrugs. 2007. PMID: 17516711 Review.

4

Intracellular activation of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus by nonpeptide agonists.

Robben JH, Kortenoeven ML, Sze M, Yae C, Milligan G, Oorschot VM, Klumperman J, Knoers NV, Deen PM. Robben JH, et al. Proc Natl Acad Sci U S A. 2009 Jul 21;106(29):12195-200. doi: 10.1073/pnas.0900130106. Epub 2009 Jul 8. Proc Natl Acad Sci U S A. 2009. PMID: 19587238 Free PMC article.

5

Succinate receptors in the kidney.

Deen PM, Robben JH. Deen PM, et al. Among authors: robben jh. J Am Soc Nephrol. 2011 Aug;22(8):1416-22. doi: 10.1681/ASN.2010050481. J Am Soc Nephrol. 2011. PMID: 21803970 Review.

6

Characterization of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus in a polarized cell model.

Robben JH, Knoers NV, Deen PM. Robben JH, et al. Am J Physiol Renal Physiol. 2005 Aug;289(2):F265-72. doi: 10.1152/ajprenal.00404.2004. Am J Physiol Renal Physiol. 2005. PMID: 16006591 Free article.

7

Rescue of vasopressin V2 receptor mutants by chemical chaperones: specificity and mechanism.

Robben JH, Sze M, Knoers NV, Deen PM. Robben JH, et al. Mol Biol Cell. 2006 Jan;17(1):379-86. doi: 10.1091/mbc.e05-06-0579. Epub 2005 Nov 2. Mol Biol Cell. 2006. PMID: 16267275 Free PMC article.

8

Functional rescue of vasopressin V2 receptor mutants in MDCK cells by pharmacochaperones: relevance to therapy of nephrogenic diabetes insipidus.

Robben JH, Sze M, Knoers NV, Deen PM. Robben JH, et al. Am J Physiol Renal Physiol. 2007 Jan;292(1):F253-60. doi: 10.1152/ajprenal.00247.2006. Epub 2006 Aug 22. Am J Physiol Renal Physiol. 2007. PMID: 16926443 Free article.

9

Potential of nonpeptide (ant)agonists to rescue vasopressin V2 receptor mutants for the treatment of X-linked nephrogenic diabetes insipidus.

Los EL, Deen PM, Robben JH. Los EL, et al. Among authors: robben jh. J Neuroendocrinol. 2010 May;22(5):393-9. doi: 10.1111/j.1365-2826.2010.01983.x. Epub 2010 Feb 12. J Neuroendocrinol. 2010. PMID: 20163515 Review.

10

Polarisation, key to good localisation.

van Beest M, Robben JH, Savelkoul PJ, Hendriks G, Devonald MA, Konings IB, Lagendijk AK, Karet F, Deen PM. van Beest M, et al. Among authors: robben jh. Biochim Biophys Acta. 2006 Aug;1758(8):1126-33. doi: 10.1016/j.bbamem.2006.03.007. Epub 2006 Mar 31. Biochim Biophys Acta. 2006. PMID: 16630534 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters